Please use this identifier to cite or link to this item:
https://hdl.handle.net/20.500.14365/4821
Title: | Hypermetabolic Axillary Lymph Nodes Associated with COVID-19 Vaccination in Breast Cancer Management | Other Titles: | Meme Kanseri Yönetiminde COVID-19 Aşısına Bağlı Hipermetabolik Aksiller Lenf Nodları | Authors: | Taşçı, Cengiz Dirican, Ahmet Sözbilen, Ethem Murat Pehlivan, F.S. Serter, Selim |
Keywords: | 18F-FDG PET/CT Axillary lymph nodes breast cancer COVID-19 vaccination CD20 antigen CD3 antigen fluorodeoxyglucose f 18 tozinameran adjuvant chemotherapy adult Article axillary lymph node cancer radiotherapy cancer staging case report clinical article coronavirus disease 2019 female human human tissue hypermetabolism invasive ductal breast carcinoma lymph node metastasis lymphadenopathy lymphoid tissue maximum standardized uptake value neoadjuvant chemotherapy positron emission tomography-computed tomography primary tumor simple mastectomy treatment response tumor volume vaccination |
Publisher: | Galenos Publishing House | Abstract: | A 42-year-old female patient diagnosed with invasive ductal breast ca underwent18F-fluorodeoxyglucose (FDG) positron emission tomography/ computed tomography (PET/CT) scan for staging, 1.5 cm diameter hypermetabolic lesion was observed in the lower inner quadrant of the right breast that was compatible with primary tumor [maximum standardized uptake value (SUVmax ): 10.5]. No pathological18F-FDG uptake was observed in lymph nodes whose fatty hilum was seen in the right axilla. However, in the left axilla and left deep axilla, hypermetabolic lymph nodes with a maksimum diameter of 19 mm and fatty hilum were observed (SUVmax: 8.0). In a detailed CT evaluation, these lymph nodes have thicker walls than the ones in the right axilla. The patient was questioned again and coronavirus disease-2019 (COVID-19) vaccination history (with BNT162b2, COVID-19 mRNA vaccine) was determined that was administrated to the left arm 5 days ago. Tru-cut biopsy was performed from the left aksillary lymph nodes and proved to be reactive lymphoid tissue and there was no primary or metastatic tumor in these axillary lymph node tissues. The patient was given neoadjuvant chemotherapy 4.5 months after the first18F-FDG PET/CT, and the second was performed for the treatment response evaluation. Significant regression was determined from the findings. The patient underwent right total mastechtomy. She was being followed up with adjuvant chemotherapy and radiotherapy. In conclusion, hypermetabolic lymph nodes in the axillas should be interrogated for vaccination in patients with breast cancer. Hypermetabolic lymph nodes observed on the same side of the vaccinated arm in the 18 F-FDG PET/CT scan may be related to vaccine-induced reactive lymph node enlargement. Lymph node metastasis may be excluded, especially if there are hypermetabolic lymph nodes with preserved fatty hilum in the contralateral axilla on the same side as the vaccinated arm. Active lymph nodes reactive to the vaccine become inactive after a while. © 2023 by the Turkish Society of Nuclear Medicine. | URI: | https://doi.org/10.4274/mirt.galenos.2023.82712 https://hdl.handle.net/20.500.14365/4821 |
ISSN: | 2146-1414 |
Appears in Collections: | Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection TR Dizin İndeksli Yayınlar Koleksiyonu / TR Dizin Indexed Publications Collection |
Files in This Item:
File | Size | Format | |
---|---|---|---|
MIRT-32-181-En.pdf | 807.67 kB | Adobe PDF | View/Open |
CORE Recommender
Page view(s)
100
checked on Nov 18, 2024
Download(s)
12
checked on Nov 18, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.